Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Legalon SIL for HCV Recurrence After Liver Transplant
NCT01518933Phase 2Terminated
- Sponsor
- Rottapharm Biotech
- Start
- Aug 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Legalon SIL in hepatitis C (HCV), sponsored by Rottapharm Biotech. Started Aug 2011; status: terminated.
02
Drugs
Legalon SIL
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01518933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518933.